Choose Your Horizon is raising funds on StartEngine at a valuation of $14.87 million. This valuation is based on the company's annual revenue of $1.5 million, giving it a revenue multiple of 9.91x. While the revenue multiple is relatively low compared to other companies in the healthcare and pharmaceutical industry, it's important to note that Choose Your Horizon is still in the early stages of development and is focused on growth.

Investors should be cautious of the company's valuation, which may be overvalued based on its current revenue and margin levels. However, the growing demand for alternative mental health treatments and the potential for expansion into new markets could provide upside potential for investors in the long term.

Mental health has become a significant concern in the US, and the need for innovative solutions is crucial. Choose Your Horizon operates in the US Ketamine Clinics market, valued at $3.43 billion. This market is growing at a rate of 10.6%, signaling a significant opportunity for the company. However, it's worth noting that the highly regulated market could pose challenges for Choose Your Horizon.

The demand for mental wellness solutions is high, so the market potential for Choose Your Horizon is extensive. However, the market acceptance for such psychedelic treatments is relatively low, indicating that there could be challenges in terms of patient adoption and perception of psychedelic therapies.

Choose Your Horizon is led by co-founders Mark Holland and Robert Lee. Holland is the company's CEO, bringing two years of relevant industry experience. He is a dedicated and experienced leader with high-level managerial skills. Holland's expertise and passion for mental wellness have driven the development of Choose Your Horizon's at-home psychedelic therapy platform.

Lee, the COO of Choose Your Horizon, also has two years of relevant industry experience. While part-time, Lee contributes to the company's operations and growth. Holland and Lee have been dedicated to building Choose Your Horizon and expanding its reach in the mental wellness industry.

Choose Your Horizon differentiates itself in the mental wellness industry by offering at-home psychedelic therapy for mental health issues. The company provides telemedicine services through certified medical experts, allowing patients to receive treatment for PTSD, anxiety, and depression from the comfort of their own homes. This approach offers a convenient and accessible alternative to traditional in-person therapy sessions.

One of the key aspects of Choose Your Horizon's offering is the use of a safe and effective sublingual tablet form of ketamine. This allows patients to undergo therapy under medical supervision without requiring invasive procedures or hospital visits. By providing a more comfortable and convenient treatment option, Choose Your Horizon aims to attract individuals who may be hesitant or unable to access traditional therapies.

Overall, Choose Your Horizon's disruptive approach to mental wellness, combined with its telemedicine platform, sublingual ketamine therapy, and ambitious expansion plans, position the company as a strong contender in the growing market for at-home psychedelic therapy.

Financially, Choose Your Horizon has achieved impressive revenue growth, with annual revenue reaching $1.5 million. The company has a solid foundation and has raised $1.43 million in prior funding rounds. 

While specific traction metrics are unavailable, Choose Your Horizon has already established a user base and has paying customers. The company is actively expanding its services and aims to offer at-home ketamine therapy in all 50 states by the end of 2024.

Choose Your Horizon operates in a slightly competitive landscape, but its unique approach to mental wellness and its focus on accessibility set it apart from traditional treatment options. The company's growth stage and seed funding indicate a promising future as it continues to develop its product offerings, expand its team, and increase its market presence.

Investing in Choose Your Horizon carries certain risks that potential investors should consider. Firstly, the company operates in a highly regulated industry with high market approval and license regulations. This can create barriers to entry and increase the complexity and time required to obtain the necessary approvals and licenses for its at-home psychedelic therapy offerings. Any delays or failures in obtaining these approvals could significantly impact the company's ability to generate revenue and expand its operations.

Choose Your Horizon also faces market acceptance challenges. While the concept of at-home psychedelic therapy may be appealing to some individuals, it may not have widespread acceptance in the market. The use of psychedelic substances for mental health treatment is still relatively new and not well understood by the general public. This lack of market acceptance may limit the company's potential customer base and hinder its growth.

Financially, Choose Your Horizon has a negative net income and a high monthly burn rate, indicating a reliance on external funding to sustain its operations.

The likelihood of facing legal issues is considered high for Choose Your Horizon. Operating in the healthcare industry, especially when dealing with controlled substances, exposes the company to potential legal and regulatory risks. Compliance with applicable laws and regulations is crucial to avoid costly litigation and penalties.

Choose Your Horizon is a mental wellness company that is transforming lives through its at-home psychedelic therapy for mental health issues. With its telemedicine platform and certified medical experts, Choose Your Horizon offers a safe and effective alternative to traditional medications for individuals dealing with PTSD, anxiety, and depression.

The market potential for Choose Your Horizon is high, given the increasing demand for mental health solutions and the growing acceptance of psychedelic therapy as a viable treatment option. The company has sold over $1.5 million in treatment packages year-to-date for 2023, indicating strong customer interest and demand.

Choose Your Horizon's at-home approach provides convenience and accessibility for patients, allowing them to undergo therapy from the comfort of their homes. This unique offering sets the company apart from traditional ketamine clinics and positions it as a leader in the emerging field of at-home psychedelic therapy.

Choose Your Horizon operates in a slightly competitive industry, offering at-home psychedelic therapy for mental health issues. While the concept of at-home therapy may appeal to some individuals, several concerns and risks are associated with this business model.

The use of ketamine for mental health treatment is still a relatively new and evolving field. It is important to note that there is limited scientific evidence supporting the long-term efficacy and safety of ketamine therapy. As a result, there may be regulatory challenges and potential legal hurdles that Choose Your Horizon could face as it expands and offer its services in more states.

Choose Your Horizon is a mental wellness company that offers at-home psychedelic therapy for mental health issues such as PTSD, anxiety, and depression. The company provides telemedicine services through certified medical experts, allowing patients to take a safe and effective sublingual tablet form of ketamine under supervision and from the comfort of home. This innovative approach positions Choose Your Horizon as an alternative to traditional medications that often come with negative side effects.

While the company has yet to profit, it has shown significant growth, with over $1.5 million in treatment packages sold year-to-date for 2023. Currently available in 13 states, Choose Your Horizon is expanding and aims to offer its at-home ketamine therapy in all 50 states by the end of 2024.

However, it's worth noting that the company operates in a highly regulated industry with high barriers to entry. Despite these challenges, Choose Your Horizon has raised over $1.4 million in previous funding rounds and is seeking additional capital through crowdfunding. The funds will be used for sales and marketing, operations, salaries, product and service development, and state expansion.